Back to top

oncology-screening: Archive

Ahan Chakraborty

Will LLY's Oncology Portfolio Provide Key Diversification Benefits?

Eli Lilly's oncology portfolio, led by Verzenio and Jaypirca, is adding diversification to its cardiometabolic-driven growth story.

AZNPositive Net Change PFEPositive Net Change MRKPositive Net Change LLYPositive Net Change